Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

Donnie Funch,1 Kathleen Mortimer,1 Najat J Ziyadeh,1 John D Seeger,1 Li Zhou,1 Eva Ng,1 Douglas Ross,2,3 Atheline Major-Pedersen,4 Heidrun Bosch-Traberg,5 Helge Gydesen,6 David D Dore1,7 1Optum Epidemiology, Boston, MA, USA; 2Massachusetts General Hospital, Thyroid Associates, Boston, MA, USA; 3Harv...

Full description

Saved in:
Bibliographic Details
Main Authors: Funch D, Mortimer K, Ziyadeh NJ, Seeger JD, Zhou L, Ng E, Ross D, Major-Pedersen A, Bosch-Traberg H, Gydesen H, Dore DD
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
glucagon-like peptide-1 receptor agonist
type 2 diabetes
administrative claims
intention-to-treat
time-on-drug
Specialties of internal medicine
RC581-951
Online Access:https://doaj.org/article/87c8c0f05a3e446986f9dbf031063a2b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/87c8c0f05a3e446986f9dbf031063a2b

Similar Items